Krensavage Asset Management as of March 31, 2016
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 22 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Baxalta Incorporated | 10.7 | $30M | 735k | 40.40 | |
| Orthofix International Nv Com Stk | 9.6 | $27M | 643k | 41.52 | |
| Enanta Pharmaceuticals (ENTA) | 9.3 | $26M | 883k | 29.37 | |
| United Therapeutics Corporation (UTHR) | 8.9 | $25M | 223k | 111.43 | |
| Teva Pharmaceutical Industries (TEVA) | 7.6 | $21M | 395k | 53.51 | |
| Impax Laboratories | 6.8 | $19M | 588k | 32.02 | |
| Halyard Health | 5.8 | $16M | 562k | 28.73 | |
| Amgen | 5.8 | $16M | 107k | 149.93 | |
| RTI Biologics | 4.9 | $14M | 3.4M | 4.00 | |
| CONMED Corporation (CNMD) | 4.9 | $14M | 328k | 41.94 | |
| Merck & Co (MRK) | 4.9 | $14M | 256k | 52.91 | |
| Indivior | 4.0 | $11M | 4.7M | 2.34 | |
| Invacare Corporation | 2.9 | $8.1M | 612k | 13.17 | |
| Allergan | 2.5 | $7.0M | 26k | 268.02 | |
| Spectrum Pharmaceuticals | 2.5 | $6.9M | 1.1M | 6.36 | |
| DepoMed | 2.2 | $6.2M | 447k | 13.93 | |
| Sucampo Pharmaceuticals | 2.2 | $6.1M | 558k | 10.93 | |
| Biota Pharmaceuticals Inc cs | 1.5 | $4.0M | 2.7M | 1.50 | |
| Derma Sciences | 1.0 | $2.8M | 906k | 3.10 | |
| Digirad Corporation | 0.9 | $2.4M | 479k | 4.96 | |
| Juniper Pharmaceuticals Incorporated | 0.7 | $1.9M | 287k | 6.61 | |
| Hill-Rom Holdings | 0.6 | $1.7M | 34k | 50.29 |
